Agronomy & Cultivation Science
Michigan Senate Bills Aim to Transfer Industrial Hemp Program Oversight to USDA, Reduce Grower Costs
Michigan's industrial hemp policy is under review, with proposed legislation aiming to transfer oversight to the USDA. Learn how this shift could reduce g…
A new Pew Research Center poll indicates widespread US cannabis legalisation support, with 88% backing medical or full legalisation. Understand the demogr…
Access & Prescribing (Australia & Global)
UK Patient Survey Suggests Significant Symptom Improvement for Mental Health Patients Using Medical Cannabis
A large UK patient survey suggests nearly all individuals prescribed medical cannabis for anxiety, depression, or PTSD reported symptom improvement and be…
Access & Prescribing (Australia & Global)
Navigating the Two-Tier System: Challenges for Medicinal Cannabis Access in the UK
UK medicinal cannabis access is a two-tier system. RCN Congress discussed NHS prescribing limits vs. private clinics, impacting patient equity. Clearer st…
Access & Prescribing (Australia & Global)
Risks and Challenges for ASX Cannabis Stocks in Australia’s Medicinal Sector
Explore the key risks impacting ASX cannabis stocks, including market volatility, regulatory hurdles, and funding challenges within Australia's evolving m…
Access & Prescribing (Australia & Global)
Federal Cannabis Rescheduling Hearing Set as Hemp THC Ban Looms and Market Dynamics Shift
As the DEA prepares for a federal cannabis rescheduling hearing, industry stakeholders and opponents are filing to participate. This report also covers th…
Agronomy & Cultivation Science
Spain and Portugal Launch HEMPVALUE Project to Develop Cross-Border Industrial Hemp Value Chain
Spain and Portugal have launched the HEMPVALUE project, a €1.3 million initiative to build a cross-border industrial hemp value chain. Discover how this p…
Australian Cannabis Policy & Law
NSW Hemp Leaders Highlight Regulatory Overlap and Inconsistency at Senate Inquiry
NSW industrial hemp leaders voiced concerns at a Senate inquiry regarding regulatory overlap with medicinal cannabis and inconsistent state rules, impacti…
Australian Cannabis Policy & Law
Factors Shaping the Outlook for ASX Cannabis Stocks in Australia’s Medicinal Market
Explore the key factors influencing ASX cannabis stocks, including commercial adoption, operational execution, and healthcare research, within Australia's…
Australian Cannabis Policy & Law
ASX Cannabis Stocks: Evolving Assessment Criteria for Medicinal Cannabis Companies
Australia's medicinal cannabis industry is maturing, shifting how ASX cannabis stocks are evaluated. Discover the key commercial, operational, and regulat…
